Managing Haemophilia for Life: 5th Haemophilia Global Summit

The 5th Haemophilia Global Summit was held in Barcelona, Spain, in September 2014. The programme was designed by an independent Scientific Steering Committee of haemophilia experts and explored issues relevant to the practical management of haemophilia, as well as key opportunities and challenges for care in the future. The topics outlined in this supplement were selected by the Scientific Steering Committee for their relevance to improving haemophilia care globally. In this supplement from the meeting, Gerry Dolan explores pharmacokinetics and dynamics in haemophilia, and Gerry Dolan and Ian Jennings jointly address the role of the laboratory in haemophilia care. The potential benefits of low‐dose prophylaxis regimens for people with haemophilia in the developing world are reviewed by Jerzy Windyga, and the question of whether ‘Future haemophilia research should be undertaken in the developing world’ is debated by Jerzy Windyga and Cedric Hermans. Management strategies for ankle arthropathy are discussed by Sébastien Lobet and E. Carlos Rodríguez‐Merchán, and the use of ultrasound for the early detection of haemophilic arthropathy is addressed by Matteo Nicola Dario Di Minno and Víctor Jiménez‐Yuste. Finally, the role of patients in the future of haemophilia care is reviewed by Brian O'Mahony.

[1]  E. Rodríguez‐Merchán Joint Surgery in the Adult Patient with Hemophilia , 2015 .

[2]  C. Martín-Hervás Imaging of the Hemophilic Joints , 2015 .

[3]  V. Jiménez‐Yuste,et al.  Radiosynovectomy in haemophilia: long-term results of 500 procedures performed in a 38-year period. , 2014, Thrombosis research.

[4]  V. Laux,et al.  Evaluation of the activated partial thromboplastin time assay for clinical monitoring of PEGylated recombinant factor VIII (BAY 94‐9027) for haemophilia A , 2014, Haemophilia : the official journal of the World Federation of Hemophilia.

[5]  A. Kent,et al.  Pfizer‐sponsored satellite symposium at the European Haemophilia Consortium (EHC) Congress , 2014, European journal of haematology. Supplementum.

[6]  C. Kessler,et al.  Prophylaxis in real life scenarios , 2014, Haemophilia : the official journal of the World Federation of Hemophilia.

[7]  A. Srivastava Haemophilia care – beyond the treatment guidelines , 2014, Haemophilia : the official journal of the World Federation of Hemophilia.

[8]  S. Kitchen,et al.  Monitoring of modified factor VIII and IX products , 2014, Haemophilia : the official journal of the World Federation of Hemophilia.

[9]  P. Giangrande,et al.  The European standards of Haemophilia Centres. , 2014, Blood transfusion = Trasfusione del sangue.

[10]  M. Davies,et al.  Assessment of a Three-Grade Classification of Complications in Total Ankle Replacement , 2014, Foot & ankle international.

[11]  L. Valentino,et al.  Towards personalizing haemophilia care: using the Haemophilia Severity Score to assess 178 patients in a single institution , 2014, Haemophilia : the official journal of the World Federation of Hemophilia.

[12]  B. Konkle,et al.  Comparative field study evaluating the activity of recombinant factor VIII Fc fusion protein in plasma samples at clinical haemostasis laboratories , 2013, Haemophilia : the official journal of the World Federation of Hemophilia.

[13]  N. Fotiadis,et al.  Hemophilic arthropathy: a review of imaging and staging. , 2013, Seminars in ultrasound, CT, and MR.

[14]  K. A. Stafford,et al.  Evidence of clinically significant extravascular stores of factor IX , 2013, Journal of thrombosis and haemostasis : JTH.

[15]  E. Berntorp Pharmacokinetics of plasma‐derived and recombinant factor IX: using population pharmacokinetics with sparse sampling data needs further study , 2013, Haemophilia : the official journal of the World Federation of Hemophilia.

[16]  S. Björkman Pharmacokinetics of plasma‐derived and recombinant factor IX – implications for prophylaxis and on‐demand therapy , 2013, Haemophilia : the official journal of the World Federation of Hemophilia.

[17]  M. Franchini,et al.  Arthropathy in Patients with Moderate Hemophilia A: A Systematic Review of the Literature , 2013, Seminars in Thrombosis & Hemostasis.

[18]  A. Čeponis,et al.  Rapid musculoskeletal ultrasound for painful episodes in adult haemophilia patients , 2013, Haemophilia.

[19]  L. Prihodova,et al.  Haemophilia care in Europe – a survey of 35 countries , 2013, Haemophilia : the official journal of the World Federation of Hemophilia.

[20]  Christine Detrembleur,et al.  Three-Dimensional Gait Analysis Can Shed New Light on Walking in Patients with Haemophilia , 2013, TheScientificWorldJournal.

[21]  P. Mannucci,et al.  Evolution of the European guidelines for the clinical development of factor VIII products: little progress towards improved patient management , 2013, Haemophilia : the official journal of the World Federation of Hemophilia.

[22]  J. Luck,et al.  Ankle fusion in patients with haemophilia , 2013, Haemophilia : the official journal of the World Federation of Hemophilia.

[23]  M. Salvatore,et al.  Magnetic resonance imaging and ultrasound evaluation of “healthy” joints in young subjects with severe haemophilia A , 2013, Haemophilia : the official journal of the World Federation of Hemophilia.

[24]  J. Dodt,et al.  Recommendations on the potency labelling of factor VIII and factor IX concentrates , 2013, Journal of thrombosis and haemostasis : JTH.

[25]  M. Morfini,et al.  Development and definition of a simplified scanning procedure and scoring method for Haemophilia Early Arthropathy Detection with Ultrasound (HEAD-US) , 2013, Thrombosis and Haemostasis.

[26]  Guy Young,et al.  Thrombin generation and whole blood viscoelastic assays in the management of hemophilia: current state of art and future perspectives. , 2013, Blood.

[27]  Enshui Zhang,et al.  Arthroscopic Ankle Arthrodesis in Hemophilic Arthropathy , 2013, Foot & ankle international.

[28]  S. Israels,et al.  Musculoskeletal health of subjects with hemophilia A treated with tailored prophylaxis: Canadian Hemophilia Primary Prophylaxis (CHPS) Study , 2013, Journal of thrombosis and haemostasis : JTH.

[29]  S. Kitchen,et al.  Quality in Laboratory Hemostasis and Thrombosis, Second Edition , 2013 .

[30]  M. Laffan,et al.  Guidelines on the laboratory aspects of assays used in haemostasis and thrombosis , 2013, International journal of laboratory hematology.

[31]  X. Zhang,et al.  Short‐term low‐dose secondary prophylaxis for severe/moderate haemophilia A children is beneficial to reduce bleed and improve daily activity, but there are obstacle in its execution: a multi‐centre pilot study in China , 2013, Haemophilia : the official journal of the World Federation of Hemophilia.

[32]  J. P. Dijk,et al.  A survey of the outcome of prophylaxis, on‐demand treatment or combined treatment in 18–35‐year old men with severe haemophilia in six countries , 2013, Haemophilia : the official journal of the World Federation of Hemophilia.

[33]  C. Hermans,et al.  The European Principles of Haemophilia Care: a pilot investigation of adherence to the principles in Europe , 2013, Haemophilia : the official journal of the World Federation of Hemophilia.

[34]  R. Liesner,et al.  Diagnosis and treatment of factor VIII and IX inhibitors in congenital haemophilia: (4th edition) , 2013, British journal of haematology.

[35]  J. Mahlangu,et al.  Guidelines for the management of hemophilia , 2013, Haemophilia : the official journal of the World Federation of Hemophilia.

[36]  E. Rodríguez‐Merchán Orthopaedic problems about the ankle in hemophilia. , 2012, The Journal of foot and ankle surgery : official publication of the American College of Foot and Ankle Surgeons.

[37]  L. Vulpen,et al.  Joint distraction: a treatment to consider for haemophilic arthropathy , 2012, Haemophilia : the official journal of the World Federation of Hemophilia.

[38]  Victor Valderrabano,et al.  Biomechanics and pathomechanisms of osteoarthritis. , 2012, Swiss medical weekly.

[39]  M. Skinner WFH: Closing the global gap – achieving optimal care , 2012, Haemophilia : the official journal of the World Federation of Hemophilia.

[40]  C. Detrembleur,et al.  Impact of ankle osteoarthritis on the energetics and mechanics of gait: the case of hemophilic arthropathy. , 2012, Clinical biomechanics.

[41]  P. Collins,et al.  Personalized prophylaxis , 2012, Haemophilia : the official journal of the World Federation of Hemophilia.

[42]  E. Rodríguez‐Merchán,et al.  The role of ultrasonography in the diagnosis of the musculo‐skeletal problems of haemophilia , 2012, Haemophilia : the official journal of the World Federation of Hemophilia.

[43]  K. Kurnik,et al.  Identification and long‐term observation of early joint damage by magnetic resonance imaging in clinically asymptomatic joints in patients with haemophilia A or B despite prophylaxis , 2012, Haemophilia : the official journal of the World Federation of Hemophilia.

[44]  C. Detrembleur,et al.  Functional impact of custom‐made foot orthoses in patients with haemophilic ankle arthropathy , 2012, Haemophilia : the official journal of the World Federation of Hemophilia.

[45]  J. Dumont,et al.  Safety and prolonged activity of recombinant factor VIII Fc fusion protein in hemophilia A patients. , 2012, Blood.

[46]  K. Mann,et al.  The influence of prophylactic factor VIII in severe haemophilia A , 2012, Haemophilia : the official journal of the World Federation of Hemophilia.

[47]  C. Ternisien,et al.  The use of the new ReFacto AF Laboratory Standard allows reliable measurement of FVIII:C levels in ReFacto AF mock plasma samples by a one‐stage clotting assay , 2011, Haemophilia : the official journal of the World Federation of Hemophilia.

[48]  L. Prihodova,et al.  A survey of the outcome of prophylaxis, on‐demand or combined treatment in 20–35 year old men with severe haemophilia in four European countries , 2011, Haemophilia : the official journal of the World Federation of Hemophilia.

[49]  Christine A. Lee,et al.  Joint protection in haemophilia , 2011, Haemophilia : the official journal of the World Federation of Hemophilia.

[50]  L. Valentino,et al.  Current and Future Issues in Hemophilia Care: Rodríguez-Merchán/Current and Future Issues in Hemophilia Care , 2011 .

[51]  V. Jiménez‐Yuste,et al.  Radiosynovectomy in hemophilia: quantification of its effectiveness through the assessment of 10 articular parameters , 2011, Journal of thrombosis and haemostasis : JTH.

[52]  M. Morfini,et al.  Implications of coagulation factor VIII and IX pharmacokinetics in the prophylactic treatment of haemophilia , 2011, Haemophilia : the official journal of the World Federation of Hemophilia.

[53]  R. Wu,et al.  Low dose secondary prophylaxis reduces joint bleeding in severe and moderate haemophilic children: a pilot study in China , 2011, Haemophilia : the official journal of the World Federation of Hemophilia.

[54]  E. Duncan,et al.  High incidence of ankle arthropathy in mild and moderate haemophilia A , 2010, Thrombosis and Haemostasis.

[55]  B. O’Mahony An introduction to key concepts in health economics for haemophilia organisations , 2011 .

[56]  J. Wiedel,et al.  Arthrodesis of the ankle and subtalar joints in patients with haemophilic arthropathy , 2010, Haemophilia : the official journal of the World Federation of Hemophilia.

[57]  B. Hintermann,et al.  Haemophilic arthropathy of the ankle treated by total ankle replacement: a case series , 2010, Haemophilia : the official journal of the World Federation of Hemophilia.

[58]  S. Björkman Limited blood sampling for pharmacokinetic dose tailoring of FVIII in the prophylactic treatment of haemophilia A , 2010, Haemophilia : the official journal of the World Federation of Hemophilia.

[59]  A. Doria State‐of‐the‐art imaging techniques for the evaluation of haemophilic arthropathy: present and future , 2010, Haemophilia : the official journal of the World Federation of Hemophilia.

[60]  G. Spotts,et al.  Comparative pharmacokinetics of plasma- and albumin-free recombinant factor VIII in children and adults: the influence of blood sampling schedule on observed age-related differences and implications for dose tailoring , 2010, Journal of thrombosis and haemostasis : JTH.

[61]  M. Clerici,et al.  Severe hemophilia with mild bleeding phenotype: molecular characterization and global coagulation profile , 2010, Journal of thrombosis and haemostasis : JTH.

[62]  K. Fischer,et al.  Factor VIII requirement to maintain a target plasma level in the prophylactic treatment of severe hemophilia A: influences of variance in pharmacokinetics and treatment regimens , 2010, Journal of thrombosis and haemostasis : JTH.

[63]  J. Stonebraker,et al.  A study of reported factor VIII use around the world , 2010, Haemophilia : the official journal of the World Federation of Hemophilia.

[64]  A. Amendola,et al.  Total ankle replacement: why, when and how? , 2010, The Iowa orthopaedic journal.

[65]  G. Dolan,et al.  Changing patterns of bleeding in patients with severe haemophilia A , 2009, Haemophilia : the official journal of the World Federation of Hemophilia.

[66]  N. Fotiadis,et al.  Imaging and staging of haemophilic arthropathy. , 2009, Clinical radiology.

[67]  B. Hintermann,et al.  Etiology of Ankle Osteoarthritis , 2009, Clinical orthopaedics and related research.

[68]  J. Astermark,et al.  Break‐through bleeding in relation to predicted factor VIII levels in patients receiving prophylactic treatment for severe hemophilia A , 2009, Journal of thrombosis and haemostasis : JTH.

[69]  S. Kitchen,et al.  Laboratory performance in the World Federation of Hemophilia EQA programme, 2003–2008 , 2009, Haemophilia : the official journal of the World Federation of Hemophilia.

[70]  T. Brown,et al.  The effect of incongruity and instability on contact stress directional gradients in human cadaveric ankles. , 2008, Osteoarthritis and cartilage.

[71]  R. Thomas,et al.  Etiology and biomechanics of ankle arthritis. , 2008, Foot and ankle clinics.

[72]  G. Spotts,et al.  Plasma and albumin‐free recombinant factor VIII: pharmacokinetics, efficacy and safety in previously treated pediatric patients , 2008, Journal of thrombosis and haemostasis : JTH.

[73]  D. Dimichele,et al.  Ethical considerations in clinical investigation: exploring relevance in haemophilia research , 2008, Haemophilia : the official journal of the World Federation of Hemophilia.

[74]  P Lundgren,et al.  Invasive in vivo measurement of rear-, mid- and forefoot motion during walking. , 2008, Gait & posture.

[75]  J. Astermark,et al.  European principles of haemophilia care , 2008, Haemophilia : the official journal of the World Federation of Hemophilia.

[76]  Vinzenz von Tscharner,et al.  Gait analysis in ankle osteoarthritis and total ankle replacement. , 2007, Clinical biomechanics.

[77]  Alan R. Cohen,et al.  Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. , 2007, The New England journal of medicine.

[78]  Christine Detrembleur,et al.  The up and down bobbing of human walking: a compromise between muscle work and efficiency , 2007, The Journal of physiology.

[79]  P. Babyn,et al.  Sonography for assessment of haemophilic arthropathy in children: a systematic protocol , 2007, Haemophilia : the official journal of the World Federation of Hemophilia.

[80]  E. Rodríguez‐Merchán The haemophilic ankle , 2006, Haemophilia : the official journal of the World Federation of Hemophilia.

[81]  P. Babyn,et al.  Tailored prophylaxis in severe hemophilia A: interim results from the first 5 years of the Canadian Hemophilia Primary Prophylaxis Study , 2006, Journal of thrombosis and haemostasis : JTH.

[82]  T. Wallny,et al.  Achilles tendon lengthening for ankle equinus deformity in hemophiliacs: 23 patients followed for 1–24 years , 2006, Acta orthopaedica.

[83]  A. Chuansumrit,et al.  Hemophilia treatment in developing countries: products and protocols. , 2005, Seminars in thrombosis and hemostasis.

[84]  P. Babyn,et al.  Compatible scales for progressive and additive MRI assessments of haemophilic arthropathy , 2005, Haemophilia : the official journal of the World Federation of Hemophilia.

[85]  J. Ahnström,et al.  A 6‐year follow‐up of dosing, coagulation factor levels and bleedings in relation to joint status in the prophylactic treatment of haemophilia , 2004, Haemophilia : the official journal of the World Federation of Hemophilia.

[86]  Ezekiel J Emanuel,et al.  What makes clinical research in developing countries ethical? The benchmarks of ethical research. , 2004, The Journal of infectious diseases.

[87]  M. Makris,et al.  SSC/ISTH classification of hemophilia A: can hemophilia center laboratories achieve the new criteria? , 2004, Journal of thrombosis and haemostasis : JTH.

[88]  T. Barrowcliffe,et al.  Standardization of FVIII & FIX assays , 2003, Haemophilia : the official journal of the World Federation of Hemophilia.

[89]  K. Pasi,et al.  Haemophilias A and B , 2003, The Lancet.

[90]  R. Nuss,et al.  Radiological assessment of haemophilic arthropathy with emphasis on MRI findings , 2003, Haemophilia : the official journal of the World Federation of Hemophilia.

[91]  S. Björkman Prophylactic dosing of factor VIII and factor IX from a clinical pharmacokinetic perspective , 2003, Haemophilia : the official journal of the World Federation of Hemophilia.

[92]  C. Rothschild,et al.  A blinded in vitro study with Refacto® mock plasma samples: similar FVIII results between the chromogenic assay and a one‐stage assay when using a higher cephalin dilution , 2002, Haemophilia : the official journal of the World Federation of Hemophilia.

[93]  T. Barrowcliffe,et al.  Coagulation and Chromogenic Assays of Factor VIII Activity: General Aspects, Standardization, and Recommendations , 2002, Seminars in thrombosis and hemostasis.

[94]  M. Mikaelsson,et al.  Assaying the circulating factor VIII activity in hemophilia A patients treated with recombinant factor VIII products. , 2002, Seminars in thrombosis and hemostasis.

[95]  P. Isarangkura Haemophilia care in the developing world: benchmarking for excellence , 2002, Haemophilia : the official journal of the World Federation of Hemophilia.

[96]  T. Klingebiel,et al.  Modified magnetic resonance imaging score compared with orthopaedic and radiological scores for the evaluation of haemophilic arthropathy , 2002, Haemophilia : the official journal of the World Federation of Hemophilia.

[97]  J. Aznar,et al.  Results of an orthopaedic survey in young patients with severe haemophilia in Spain , 2002, Haemophilia : the official journal of the World Federation of Hemophilia.

[98]  M. Manco‐Johnson,et al.  Barriers to compliance with prophylaxis therapy in haemophilia , 2001, Haemophilia : the official journal of the World Federation of Hemophilia.

[99]  M. Mikaelsson,et al.  Measurement of factor VIII activity of B-domain deleted recombinant factor VIII. , 2001, Seminars in hematology.

[100]  F. Beek,et al.  Long‐term outcome of individualized prophylactic treatment of children with severe haemophilia , 2001, British journal of haematology.

[101]  M. Dalyan,et al.  Hemophilic arthropathy: evaluation of clinical and radiological characteristics and disability. , 2000, The Turkish journal of pediatrics.

[102]  C. Kessler,et al.  Influence of phospholipids on the assessment of factor VIII activity , 1998, Haemophilia : the official journal of the World Federation of Hemophilia.

[103]  I. Nilsson,et al.  Radioactive synoviorthesis in patients with hemophilia with factor inhibitor. , 1997, Clinical orthopaedics and related research.

[104]  Smith Ma,et al.  Supramalleolar tibial osteotomy for haemophilic arthropathy of the ankle , 1994 .

[105]  M. Pearce,et al.  Supramalleolar tibial osteotomy for haemophilic arthropathy of the ankle. , 1994, The Journal of bone and joint surgery. British volume.

[106]  M. Gilbert Prophylaxis: musculoskeletal evaluation. , 1993, Seminars in hematology.

[107]  H. Pınar,et al.  The Alici spinal system in the surgical treatment of scoliosis. , 1992, Acta orthopaedica Belgica.

[108]  J. Gago,et al.  Ultrasound in the diagnosis of the early stages of hemophilic arthropathy of the knee. , 1992, Acta orthopaedica Belgica.

[109]  W. Kisiel,et al.  In vivo evidence of intravascular binding sites for coagulation factor IX , 1987, British Journal of Haematology.

[110]  M. Chamberlain,et al.  Joint protection. , 1984, Clinics in rheumatic diseases.

[111]  A S Greenwald,et al.  Mathematical model of the human ankle joint. , 1983, Journal of biomechanics.

[112]  H. Pettersson,et al.  A radiologic classification of hemophilic arthropathy. , 1980, Clinical orthopaedics and related research.

[113]  V T Inman,et al.  Conservation of energy in ambulation. , 1967, Archives of physical medicine and rehabilitation.

[114]  F. Loth [Hemophilic arthropathy]. , 1962, Chirurgia narzadow ruchu i ortopedia polska.

[115]  G. G. King I. IN SPAIN , 1941 .